EUVIMEDEUVIMED entdecken
Crossref

Targeted nanocarriers effectively remove cholesterol from macrophages

Jin Chen iD, Qing Miao iD, Xinrong Xiao iD

Bio-Medical Materials and Engineering · 2026

DOI: 10.1177/09592989251375811 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Bio-Medical Materials and Engineering, 2026. Verfasst von Jin Chen und 2 weiteren Autor:innen. Beteiligte Einrichtung: School of Chemistry and Chemical Engineering, University of South China, Hengyang, People's Republic of China. Hauptthemen laut MEDLINE: Nanoparticle Drug Delivery System, Macrophages, Dendrimers, Cholesterol. Die Arbeit nennt 35 Literaturangaben. Gefördert von: University of South China Innovation Foundation For Postgraduate, Science and Technology Plan Funded Project of Hunan province.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Macrophages phagocytose large amounts of cholesterol to form foam cells that can aggravate inflammation and further promote the development of atherosclerotic plaque.

Objective

To develop novel nanocarriers targeting atherosclerosis-associated macrophages.

Methods

CD-G5 was obtained by modifying β-CD onto PAMAM G5.0, and subsequently PEG2000 was used as a linker arm to modify mannose onto PAMAM G5.0 of CD-G5 to obtain CD-G5-PEG-Man. CD-G5-PEG-Man was structurally characterized and evaluated in vitro for its cell biological functions.

Results

CD-G5-PEG-Man had an average particle size of 110 nm and a regular spherical morphology. CD-G5-PEG-Man showed no significant toxicity to macrophages at all the experimental concentration gradients. Macrophages showed stronger uptake of the fluorescently labelled nanoparticle CD-G5-PEG-Man-FITC than CD-G5-FITC, and the fluorescence weakened with increasing free mannose. Intracellular BODIY-cholesterol fluorescence intensity was weaker in the 200 nM CD-G5-PEG-Man treatment group than in the 100 µM HP-β-CD, 100 nM CD-G5-PEG-Man, and DMSO treatment groups. The higher the amount of β-CD on the CD-G5-PEG-Man, the lower the fluorescence intensity of intracellular BODIY-cholesterol.

Conclusion

A biosafety nanocarrier, CD-G5-PEG-Man, was successfully developed, in which mannose specifically targets macrophages via mannose receptors on macrophages, and β-CD synergistically promotes cholesterol efflux from macrophages.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Nanoparticle Drug Delivery SystemMacrophagesDendrimersCholesterolbeta-CyclodextrinsNanoparticlesAtherosclerosisRAW 264.7 CellsAnimalsMiceMannosePolyethylene GlycolsFoam CellsPrimary Cell CultureToxicity Tests, AcuteCell Survival

Stichwörter der Autor:innen

PAMAMcholesterol effluxcyclodextrinsmacrophagestargeted nanoparticles

Substanzen

Nanoparticle Drug Delivery SystemPAMAM StarburstDendrimersCholesterolbeta-CyclodextrinsMannosePolyethylene Glycols

Autor:innen und Institutionen

  • School of Chemistry and Chemical Engineering, University of South China, Hengyang, People's Republic of China.

ORCID-Profile: Jin Chen, Qing Miao, Xinrong Xiao

Förderung

  • University of South China Innovation Foundation For Postgraduate
  • Science and Technology Plan Funded Project of Hunan province

Zitieren

APA

Chen, J., Miao, Q., & Xiao, X. (2026). Targeted nanocarriers effectively remove cholesterol from macrophages. Bio-Medical Materials and Engineering. https://doi.org/10.1177/09592989251375811

Vancouver

Chen J, Miao Q, Xiao X. Targeted nanocarriers effectively remove cholesterol from macrophages. Bio-Medical Materials and Engineering. 2026. doi:10.1177/09592989251375811

BibTeX
@article{Chen2026,
  author = {Chen, Jin and Miao, Qing and Xiao, Xinrong},
  title = {Targeted nanocarriers effectively remove cholesterol from macrophages},
  journal = {Bio-Medical Materials and Engineering},
  year = {2026},
  doi = {10.1177/09592989251375811}
}
Kostenlos starten →